SCHEMBL30424015

SCHEMBL30424015

c1cc(-c2cn[nH]c2)cc(-c2cn[nH]c2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 3/20 0.71
AKT1 P31749 1/20 0.71
RPS6KA3 P51812 1/20 0.51
PIM1 P11309 3/20 0.47
PIM3 Q86V86 1/20 0.47
PIM2 Q9P1W9 1/20 0.47
CHEK1 O14757 5/20 0.46
CHEK2 O96017 1/20 0.46
ILK Q13418 1/20 0.46
ACVR1 Q04771 1/20 0.45
NT5E P21589 1/20 0.44
ROCK2 O75116 1/20 0.43
CLK2 P49760 2/20 0.43
HIPK1 Q86Z02 2/20 0.43
HIPK2 Q9H2X6 2/20 0.43
HIPK3 Q9H422 2/20 0.43
CLK4 Q9HAZ1 2/20 0.43
CLK1 P49759 1/20 0.43
CLK3 P49761 1/20 0.43
DYRK1A Q13627 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27812271 0.87 AKT1 (0.55) AKT2AKT1RPS6KA3PIM1PIM3
SCHEMBL28941664 0.86 AKT2 (0.87) AKT2AKT1PIM1CHEK1CHEK2
SCHEMBL15606681 0.86 AKT2 (0.87) AKT2AKT1PIM1CHEK1CHEK2
SCHEMBL23804742 0.86 AKT2 (0.59) AKT2AKT1CHEK1ROCK2
SCHEMBL20597906 0.86 AKT2 (0.59) AKT2AKT1RPS6KA3PIM1PIM3
SCHEMBL17980346 0.86 NT5E (0.59) AKT2AKT1RPS6KA3CHEK1NT5E
SCHEMBL980068 0.86 CHEK1 (0.59) AKT2AKT1RPS6KA3CHEK1ROCK2
SCHEMBL22861241 0.86 AKT2 (0.59) AKT2AKT1RPS6KA3PIM1PIM3
SCHEMBL4582269 0.86 AKT2 (0.59) AKT2AKT1RPS6KA3PIM1PIM3
SCHEMBL3089533 0.86 AKT1 (0.59) AKT2AKT1RPS6KA3PIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008800-A1 PYRAZOLE COBALT-BASED METAL-ORGANIC FRAMEWORK MATERIAL WITH DYNAMIC PORE SIZE, METHOD FOR MAKING THE SAME, AND USE IN SULFUR HEXAFLUORIDE CAPTURE UNIV BEIJING TECHNOLOGY (CN) 2026-01-08 US claimed
CN-116139936-A Carbonic anhydrase artificial enzyme and preparation method and application thereof 四川大学 2023-05-23 CN claimed
CN-116139936-B Carbonic anhydrase artificial enzyme and preparation method and application thereof 四川大学 2023-07-04 CN disclosed
CN-116139936-B Carbonic anhydrase artificial enzyme and preparation method and application thereof 四川大学 2023-07-04 CN disclosed
CN-116139936-A Carbonic anhydrase artificial enzyme and preparation method and application thereof 四川大学 2023-05-23 CN disclosed
CN-116139936-A Carbonic anhydrase artificial enzyme and preparation method and application thereof 四川大学 2023-05-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008800-A1 PYRAZOLE COBALT-BASED METAL-ORGANIC FRAMEWORK MATERIAL WITH DYNAMIC PORE SIZE, METHOD FOR MAKING THE SAME, AND USE IN SULFUR HEXAFLUORIDE CAPTURE HBB, SFN, ABCB7 AKT2 3239/4885AKT1 3982/4885RPS6KA3 2678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.